BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taleban S, Elquza E, Gower-rousseau C, Peyrin-biroulet L. Cancer and inflammatory bowel disease in the elderly. Digestive and Liver Disease 2016;48:1105-11. [DOI: 10.1016/j.dld.2016.05.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Direito R, Rocha J, Lima A, Gonçalves MM, Duarte MP, Mateus V, Sousa C, Fernandes A, Pinto R, Boavida Ferreira R, Sepodes B, Figueira ME. Reduction of Inflammation and Colon Injury by a Spearmint Phenolic Extract in Experimental Bowel Disease in Mice. Medicines (Basel) 2019;6:E65. [PMID: 31174376 DOI: 10.3390/medicines6020065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Moutinho BD, de Barros JR, Baima JP, Saad-Hossne R, Sassaki LY. Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease. Am J Case Rep 2020;21:e920949. [PMID: 32218413 DOI: 10.12659/AJCR.920949] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Haddad A, Al-Sabbagh MQ, Al-Ani H, Siyam AM, Aborajooh E, Iwata T, Kimura S, Shariat SF, Abufaraj M. Inflammatory bowel disease and prostate cancer risk: A systematic review. Arab J Urol 2020;18:207-12. [PMID: 33312730 DOI: 10.1080/2090598X.2020.1761674] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Carchman E. Crohn's Disease and the Risk of Cancer. Clin Colon Rectal Surg 2019;32:305-13. [PMID: 31275078 DOI: 10.1055/s-0039-1683923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Song EM, Kim N, Lee SH, Chang K, Hwang SW, Park SH, Yang DH, Byeon JS, Myung SJ, Yang SK, Ye BD. Clinical characteristics and long-term prognosis of elderly-onset Crohn's disease. Scand J Gastroenterol 2018;53:417-25. [PMID: 29457917 DOI: 10.1080/00365521.2018.1437927] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
6 Kim D, Taleban S. A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population. Drugs Aging 2019;36:607-24. [PMID: 31055789 DOI: 10.1007/s40266-019-00672-x] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Butter M, Weiler S, Biedermann L, Scharl M, Rogler G, Bischoff-ferrari HA, Misselwitz B. Clinical manifestations, pathophysiology, treatment and outcome of inflammatory bowel diseases in older people. Maturitas 2018;110:71-8. [DOI: 10.1016/j.maturitas.2018.01.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
8 Shashi P, Gopalakrishnan D, Parikh MP, Shen B, Kochhar G. Efficacy and safety of vedolizumab in elderly patients with inflammatory bowel disease: a matched case-control study. Gastroenterol Rep (Oxf) 2020;8:306-11. [PMID: 32843978 DOI: 10.1093/gastro/goz041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Mota J, Direito R, Rocha J, Fernandes J, Sepodes B, Figueira ME, Raymundo A, Lima A, Ferreira RB. Lupinus albus Protein Components Inhibit MMP-2 and MMP-9 Gelatinolytic Activity In Vitro and In Vivo. Int J Mol Sci 2021;22:13286. [PMID: 34948082 DOI: 10.3390/ijms222413286] [Reference Citation Analysis]
10 Coulthard SA, Berry P, McGarrity S, McLaughlin S, Ansari A, Redfern CPF. Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone. Inflamm Bowel Dis. 2017;23:946-955. [PMID: 28452864 DOI: 10.1097/mib.0000000000001131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Direito R, Rocha J, Sepodes B, Eduardo-Figueira M. Phenolic Compounds Impact on Rheumatoid Arthritis, Inflammatory Bowel Disease and Microbiota Modulation. Pharmaceutics 2021;13:145. [PMID: 33499333 DOI: 10.3390/pharmaceutics13020145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Frasson M, Sendra L, Miguel A, Herrero MJ, Montalvá E, López-Andújar R, Martínez-Pastor J, Martí-Bonmatí L, Granero EG, Aliño S. Hydrodynamic IL10 Gene Transfer in Human Colon: Results from an "EX VIVO" Study with Potential Clinical Application in Crohn's Disease. Inflamm Bowel Dis 2017;23:1360-70. [PMID: 28708803 DOI: 10.1097/MIB.0000000000001197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Khan N, Vallarino C, Lissoos T, Darr U, Luo M. Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients. Drugs Aging 2017;34:859-68. [PMID: 29170864 DOI: 10.1007/s40266-017-0498-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
14 Abu-Sbeih H, Wang Y. Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020;26:662-668. [PMID: 31560045 DOI: 10.1093/ibd/izz212] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
15 Adams AS, Madden JM, Zhang F, Lu CY, Ross-Degnan D, Lee A, Soumerai SB, Gilden D, Chawla N, Griggs JJ. Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer. Value Health 2017;20:1345-54. [PMID: 29241894 DOI: 10.1016/j.jval.2017.05.023] [Reference Citation Analysis]